Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Quantum Polymers offers AvaSpire modified PEEK resin based plastic products

Quantum Polymers today announced the availability of extruded stock shape plastic products made with AvaSpire® resin from Solvay Advanced Polymers (Alpharetta, Ga.). AvaSpire is a modified polyetheretherketone (PEEK) resin that has been formulated to offer improved ductility, mechanical strength and higher operating temperature relative to PEEK while retaining most of the key performance attributes of PEEK at a lower price point.

11 Mar 2010

Molecular master switch plays a key role in maturation process of brain cells

About four out of every 10 cells in the brain are so-called oligodendrocytes. These cells produce the all-important myelin that coats nerve tracts, ensuring fast, energy-efficient transmission of nerve impulses.

11 Mar 2010

Veterans PTSD Project: Cannabis Science formalizes agreement with specialized FDA regulatory compliance firm

Cannabis Science, Inc., a pioneering pharmaceutical cannabis company, is pleased to announce that it has formalized its agreement with a privately owned, highly specialized international FDA regulatory compliance firm. The compliance firm will review and prepare technical data for Cannabis Science's FDA Pre-Investigative New Drug submission package for its Veterans PTSD Project.

11 Mar 2010

PBI and TDI announce strategic licensing and collaborative research and development agreement

Pressure BioSciences, Inc. and Target Discovery, Inc.,, today announced a strategic product licensing, manufacturing, co-marketing, and collaborative research and development agreement. Under the terms of the Agreement, PBI has been licensed by TDI to manufacture and sell a highly innovative line of chemicals used in the preparation of tissues for scientific analysis.

11 Mar 2010

Chelsea Therapeutics announces financial results for fourth quarter 2009

Chelsea Therapeutics International, Ltd. reported financial results for the fourth quarter and full year 2009 and will host a conference call this afternoon at 4:30 PM ET to discuss these results and provide a quarterly update on the Company's development progress.

11 Mar 2010

Discovery Laboratories reports net loss of $6.1M for fourth-quarter 2009

Discovery Laboratories, Inc. today announces financial results for the fourth quarter ended December 31, 2009 and provides a business update.

10 Mar 2010

Bavarian Nordic' Annual Report 2009

Today Bavarian Nordic published the company's Annual Report 2009. The report is available on the company's website: www.bavarian-nordic.com

10 Mar 2010

Stason Pharmaceuticals to market Unilife's Unitract 1mL safety syringe in Japan, China and Taiwan

Unilife Corporation today announced that it has signed an exclusive five-year agreement with Stason Pharmaceuticals Inc, a U.S.-based pharmaceutical company, to market the Unitract™ 1mL safety syringe in Japan, China and Taiwan. Stason's Taiwan-based strategic alliance affiliate, Standard Chem. and Pharm. Co., LTD, will act as the primary distributor of the product within these designated territories.

10 Mar 2010

Stryker's Orthopaedics division to feature two of its latest hip systems at AAOS conference

Stryker Corporation's Orthopaedics division announced today that it will feature two of its latest hip systems at this year's annual American Academy of Orthopaedic Surgeons conference being held in New Orleans – the Rejuvenate Modular Primary Hip System and the ADM Mobile Bearing Acetabular System with X3.

From Stryker 10 Mar 2010

Helix BioPharma reports 29.9% increase in total revenues for second-quarter fiscal 2010

Helix BioPharma Corp. today announced financial results for the second quarter ended January 31, 2010.

10 Mar 2010

EUCODIS Bioscience introduces phospholipases

EUCODIS Bioscience, a company providing customized enzymes to the pharmaceutical, chemical, and other industries, announced today that it has launched a panel of phospholipases, adding a new enzyme family to its product portfolio.

9 Mar 2010

Advaxis confirms long-term stability of its first clinical formulation of ADXS11-001

Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has confirmed the long-term stability of its first clinical formulation of ADXS11-001, the Company’s lead immunotherapeutic.

9 Mar 2010

Rcadia Medical Imaging receives CE Mark for COR Analyzer System

Rcadia Medical Imaging today announced that it has received a CE Mark for the COR Analyzer® System, its proprietary software that helps identify patients with significant CAD (Coronary Artery Disease) by a fully automatic analysis of coronary CT angiography (cCTA) studies. The CE Mark allows the company to market the system in the European Union and other countries that accept the CE Mark registration. The COR Analyzer is marketed in the U.S. under 510(k) clearance and Rcadia was named 2009 Best New Radiology Vendor by AuntMinnie.com.

8 Mar 2010

Poniard Pharmaceuticals reports net loss of $13.2M for fourth-quarter 2009

Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today reported financial results for the fourth quarter and year ended December 31, 2009.

8 Mar 2010

Survey challenges long-held assumption: Having health insurance is synonymous with having access to health care

A survey released today by the Center for Healthcare Research & Transformation challenges the long-held assumption that having health insurance is synonymous with having access to health care.

8 Mar 2010

NerPharMa facility receives FDA approval to manufacture CTI's drug pixantrone

Cell Therapeutics, Inc. today announced that the U.S. Food and Drug Administration has completed its inspection of the facility at NerPharMa (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy), which manufactures the CTI's drug pixantrone and has found the site in compliance and acceptable for continued manufacturing of the drug product.

8 Mar 2010

Nordic Naturals' products surpass all PCB standards set by California's Proposition 65

Nordic Naturals announced today that the company's products surpass all PCB standards set by California's Proposition 65, the GOED voluntary monograph, and all international standards. Nordic Naturals products were not listed in the lawsuit filed in California alleging that eight fish oil companies did not properly label products regarding PCB levels under the state's Proposition 65.

6 Mar 2010

Peptimmune granted US patent for PI-2301 peptide copolymer in treatment of multiple sclerosis

Peptimmune, Inc. a privately held biotechnology company, announced today the grant of US Patent Number 7,655,221 (the '221 patent) which protects the target product profile for its PI-2301 peptide copolymer for the treatment of multiple sclerosis, and other autoimmune diseases.

6 Mar 2010

GMDP retains Mina Mar Group as lead merger representative for its expansive corporate interests

Global Medical Products Holdings, Inc. (http://www.globalmedicalcorporation.com) retained the Mina Mar Group Inc. (http://www.minamargroup.com/) retained Mina Mar Group (http://www.minamargroup.com/) as the lead merger representative for the company' expansive corporate interests.

6 Mar 2010

Opexa Therapeutics reports net loss of $1,433,922 for year ended December 31, 2009

Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the year ended December 31, 2009 and provided an update on its progress.

5 Mar 2010

Manufacturing News and Research

Further Reading

Quantum Polymers offers AvaSpire modified PEEK resin based plastic products

Molecular master switch plays a key role in maturation process of brain cells

Veterans PTSD Project: Cannabis Science formalizes agreement with specialized FDA regulatory compliance firm

PBI and TDI announce strategic licensing and collaborative research and development agreement

Chelsea Therapeutics announces financial results for fourth quarter 2009

Discovery Laboratories reports net loss of $6.1M for fourth-quarter 2009

Bavarian Nordic' Annual Report 2009

Stason Pharmaceuticals to market Unilife's Unitract 1mL safety syringe in Japan, China and Taiwan

Stryker's Orthopaedics division to feature two of its latest hip systems at AAOS conference

Helix BioPharma reports 29.9% increase in total revenues for second-quarter fiscal 2010

EUCODIS Bioscience introduces phospholipases

Advaxis confirms long-term stability of its first clinical formulation of ADXS11-001

Rcadia Medical Imaging receives CE Mark for COR Analyzer System

Poniard Pharmaceuticals reports net loss of $13.2M for fourth-quarter 2009

Survey challenges long-held assumption: Having health insurance is synonymous with having access to health care

NerPharMa facility receives FDA approval to manufacture CTI's drug pixantrone

Nordic Naturals' products surpass all PCB standards set by California's Proposition 65

Peptimmune granted US patent for PI-2301 peptide copolymer in treatment of multiple sclerosis

GMDP retains Mina Mar Group as lead merger representative for its expansive corporate interests

Opexa Therapeutics reports net loss of $1,433,922 for year ended December 31, 2009

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest Life Science News